TERAPAVE® AEA

Air-entraining admixture ASTM C260

Product Description 

TERAPAVE® AEA admixture is an aqueous solution of a complex mixture of organic acid salts. Terapave AEA is specially formulated for use as an air-entraining admixture for concrete paving and provides uniform, predictable performance. It is supplied ready-to-use and does not require premixing with water. Terapave AEA conforms to ASTM C260. One gallon weighs approximately 8.5 lbs (1.02 kg/L).

Uses 

Terapave AEA is used in low slump concrete, particularly for highway paving applications, where concrete is mixed and there is a need for purposeful air entrainment. 

Performance 

Air is entrained by the development of a semi-microscopic bubble system—introduced into the mix by agitation and stabilized by Terapave AEA—in the mortar phase of the concrete. 

Terapave AEA concrete is extremely durable, particularly when subjected to freezing, thawing and deicing salts.

Addition Rates 

There is no standard addition rate for Terapave AEA. The amount to be used will depend upon the amount of air required under job conditions, usually in the range of 4% to 8%. Typical factors that might influence the amount of air entrained are: temperature, cement, sand gradation and use of extra fine materials such as fly ash. Typical Terapave AEA addition rates range from ½ to 3 fl oz/100 lbs (30 to 200 mL/100 kg) of cement.

The air-entraining efficiency of Terapave AEA becomes even greater when used with water-reducing and set-retarding agents. This may allow a reduction of up to two-thirds in the amount of Terapave AEA required for the specified air content. 

Product Advantages 

  • Uniform, predictable air entrainment in paving applications
  • Can be used in wide spectrum of mix designs
  • Superior air stability minimizes air loss during placement

Compatibility with Other Admixtures and Batch Sequencing 

Terapave AEA is compatible with most GCP admixtures as long as they are added separately to the concrete mix. In general, it is recommended that Terapave AEA be added to the concrete mix near the beginning of the batch sequence for optimum performance, preferably by “dribbling” on the sand. Different sequencing may be used if local testing shows better performance. Please see GCP Technical Bulletin TB-0110, Admixture Dispenser Discharge Line Location and Sequencing for Concrete Batching Operations for further recommendations. Terapave AEA should not come in contact with any other admixture before or during the batching process, even if diluted in mix water. Terapave AEA should not be added directly to heated water.

Pretesting of the concrete mix should be performed before use, as conditions and materials change in order to assure compatibility, and to optimize dosage rates, addition times in the batch sequencing and concrete performance. Please consult your GCP Applied Technologies representative for guidance.

Concrete Mix Adjustment 

Entrained air will increase the volume of the concrete, making it necessary to adjust the mix proportions to maintain the cement factor and yield. This may be accomplished by a reduction in water requirement and aggregate content.  

Packaging & Handling 

Terapave AEA is available in bulk, delivered in metered tank trucks, totes and drums. 

Terapave AEA freezes at about 30 °F (-1 °C), but its air-entraining properties are completely restored by thawing and thorough mechanical agitation.

Dispensing Equipment 

A complete line of automatic Terapave AEA dispensers is available. Accurate and simple, these dispensers are easily adapted to existing facilities on paving mixers and in batching plants. 

Specifications 

Concrete shall be air entrained concrete, containing 4% to 8% entrained air. The air contents in the concrete shall be determined by the pressure method (ASTM Designation C231), volumetric method (ASTM Designation C173) or gravimetric method (ASTM Designation C138). The air-entraining admixture shall be Terapave AEA, as manufactured by GCP Applied Technologies, or equal. The air-entraining admixture shall be added at the concrete mixer or batching plant in such quantities as to give the specified air contents. 

gcpat.it | Servizio clienti in Italia:: +39 02 93537291

Confidiamo che le informazioni date con la presente siano utili. Sono basate su dati e conoscenze che riteniamo vere ed accurate e sono messe a disposizione dell’utente perché li consideri, facendo le opportune verifiche. Tali informazioni non rientrano nei nostri obblighi quali fornitori e per esse nessun compenso, esplicito o implicito, viene richiesto e/o viene dato. Anche per questo non assumiamo alcuna responsabilità per l’uso di tali informazioni e per i risultati che possono essere ottenuti. Nessuna informazione, raccomandazione o suggerimento può essere intesa ad un impiego in un processo che violi qualsiasi brevetto, copyright o diritto di terzi.

TERAPAVE sono marchi registrati della GCP Applied Technologies Inc in USA o in altri stati. Questa lista di marchi registrati è stata composta usando le informazioni disponibili alla data di pubblicazione e potrebbero non riflettere accuratamente la proprietà o lo status di essi.

© Copyright 2017 GCP Applied Technologies Inc. Tutti i diritti riservati. 


GCP Applied Technologies Inc., 2325 Lakeview Parkway, Alpharetta, GA 30009, USA
GCP Italiana S.p.A. - Via Trento, 7 - 20017 Passirana di Rho, Milano, Italy
Questo documento è aggiornato solo a partire dalla data dell’ultimo indicato di seguito ed è valido solo per l'uso in Italia. È importante consultare sempre le informazioni attualmente disponibili sull'URL.di seguito per avere le informazioni sul prodotto più recenti al momento dell'uso. Documenti aggiuntivi come i manuali di utilizzo, bollettini tecnici, disegni dettagliati e raccomandazioni dettagliate e altri documenti rilevanti sono disponibili anche su www.gcpat.fr. Le informazioni trovate su altri siti web non dovrebbero essere utilizzati, in quanto potrebbero non essere aggiornati o applicabili alle condizioni del tuo paese e non ci assumiamo alcuna responsabilità quanto al loro contenuto. In caso di conflitti o se hai bisogno di ulteriori informazioni, contatta il servizio clienti di GCP.

Last Updated: 2023-06-15

https://gcpat.it/it-it/solutions/products/terapave-aea